Additionally, in comparison with other breast cancer subtypes, TNBC due to lack of expression of the estrogen receptor, progesterone receptor, and HER-2 is primarily treated with surgery and non-specific chemotherapy and radiotherapy regimens. This evidence concerns the gene ERBB2 and breast cancer.